Asset Dedication LLC’s Quest Diagnostics DGX Stock Holding History

Asset Dedication LLC’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33K	Sell	11 -173	-94%	-$34K	﹤0.01%	1020
2026 Q1	$36.1K	Buy	184 +1	+0.5%	+$194	﹤0.01%	532
2025 Q4	$31.8K	Hold	183	–	–	﹤0.01%	573
2025 Q3	$34.9K	Sell	183 -1	-0.5%	-$177	﹤0.01%	563
2025 Q2	$33.1K	Hold	184	–	–	﹤0.01%	592
2025 Q1	$31.1K	Buy	184 +1	+0.5%	+$164	﹤0.01%	561
2024 Q4	$27.6K	Hold	183	–	–	﹤0.01%	578
2024 Q3	$28.4K	Hold	183	–	–	﹤0.01%	610
2024 Q2	$25.1K	Hold	183	–	–	﹤0.01%	623
2024 Q1	$24K	Hold	183	–	–	﹤0.01%	549
2023 Q4	$25K	Hold	183	–	–	﹤0.01%	526
2023 Q3	$22K	Hold	183	–	–	﹤0.01%	539
2023 Q2	$26K	Hold	183	–	–	﹤0.01%	520
2023 Q1	$26K	Sell	183 -5	-3%	-$715	﹤0.01%	510
2022 Q4	$30K	Buy	188 +5	+3%	+$719	﹤0.01%	484
2022 Q3	$22K	Buy	+183	New	+$24.1K	﹤0.01%	508
2016 Q1	–	Sell	-75	Closed	-$5K	–	464
2015 Q4	$5K	Buy	+75	New	+$5.04K	﹤0.01%	457

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Asset Dedication LLC's DGX Position: Q2 2026 in Review

Asset Dedication LLC reduced its Quest Diagnostics (DGX) stake by 94% in Q2 2026, selling an estimated $34K and leaving 11 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Asset Dedication LLC first reported a position in DGX in Q4 2015 and has held it in 17 quarters since. The position peaked at $36.1K in Q1 2026. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Asset Dedication LLC held 11 shares of Quest Diagnostics worth $2.33K as of Q2 2026.
Asset Dedication LLC sold 173 Quest Diagnostics shares in Q2 2026, an estimated $34K.
Quest Diagnostics made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1020 holding.
Asset Dedication LLC first reported a position in Quest Diagnostics in Q4 2015 and has held it in 17 quarters since.
Asset Dedication LLC's Quest Diagnostics position peaked at $36.1K in Q1 2026.
1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.